Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Cryer

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The American Journal of Geriatric Pharmacotherapy|November 1, 2005
A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosisByron Cryer, Neil Binkley, Christine Simonelli, et al.
Clinics and Research in Hepatology and Gastroenterology|August 28, 2025
Safety and efficacy of index admission cholecystectomy in severity-stratified acute cholangitis hospitalizationsAli Jaan, Mostafa Suhail Najim, Adeena Maryyum, et al.
Gastroenterology|November 3, 2004
Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysisRick A Weideman, Kevin C Kelly, Salahuddin Kazi, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 3, 2024
Increasing Diversity in Academic Medicine Via a Strategic Intermural Housestaff Leadership Development ProgramEva Galvan, Christina E Ahn, Marissa Hansen, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 13, 2008
The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitorJohn J Warner, Rick A Weideman, Kevin C Kelly, et al.
Postgraduate Medicine|April 28, 2015
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety studyRoy D Altman, Vibeke Strand, Marc C Hochberg, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2019
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence studyDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Digestive Diseases and Sciences|March 1, 2016
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USAJason Y Park, Kerry B Dunbar, Midori Mitui, et al.
Journal of the American College of Cardiology|January 17, 2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes MellitusDeepak L Bhatt, Tilo Grosser, Jing-Fei Dong, et al.
The Journal of Rheumatology|November 4, 2009
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tractFrancis K L Chan, Byron Cryer, Jay L Goldstein, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The American Journal of Geriatric Pharmacotherapy|November 1, 2005
A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosisByron Cryer, Neil Binkley, Christine Simonelli, et al.
Clinics and Research in Hepatology and Gastroenterology|August 28, 2025
Safety and efficacy of index admission cholecystectomy in severity-stratified acute cholangitis hospitalizationsAli Jaan, Mostafa Suhail Najim, Adeena Maryyum, et al.
Gastroenterology|November 3, 2004
Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysisRick A Weideman, Kevin C Kelly, Salahuddin Kazi, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 3, 2024
Increasing Diversity in Academic Medicine Via a Strategic Intermural Housestaff Leadership Development ProgramEva Galvan, Christina E Ahn, Marissa Hansen, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 13, 2008
The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitorJohn J Warner, Rick A Weideman, Kevin C Kelly, et al.
Postgraduate Medicine|April 28, 2015
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety studyRoy D Altman, Vibeke Strand, Marc C Hochberg, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2019
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence studyDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Digestive Diseases and Sciences|March 1, 2016
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USAJason Y Park, Kerry B Dunbar, Midori Mitui, et al.
Journal of the American College of Cardiology|January 17, 2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes MellitusDeepak L Bhatt, Tilo Grosser, Jing-Fei Dong, et al.
The Journal of Rheumatology|November 4, 2009
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tractFrancis K L Chan, Byron Cryer, Jay L Goldstein, et al.
Pageof 6